Literature DB >> 5095753

More on amantadine in tardive dyskinesia.

G E Crane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5095753

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Rapid response of disabling tardive dyskinesia to amantadine: a case report.

Authors:  Gaurav Jain
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 2.  Orofacial dyskinesia. Clinical features, mechanisms and drug therapy.

Authors:  R M Kobayashi
Journal:  West J Med       Date:  1976-10

Review 3.  Amantadine Revisited: A Contender for Initial Treatment in Parkinson's Disease?

Authors:  Sarah Marmol; Matthew Feldman; Carlos Singer; Jason Margolesky
Journal:  CNS Drugs       Date:  2021-10-14       Impact factor: 5.749

Review 4.  Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials.

Authors:  Wojciech Danysz; Andrzej Dekundy; Astrid Scheschonka; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2021-02-23       Impact factor: 3.575
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.